Database: COVID-19 Studies from the World Health Organization Database
Summary of development trends of new coronavirus therapeutic agents and vaccines [COVID-19](UPDATE on May 22) When will the new coronavirus vaccine be available? Vaccine types and their constituents Global Vaccine Market Features and Trends WHO Catching Up to Coronavirus: Top 60 Treatments in Development The virus that causes COVID-19 is named "SARS-CoV-2". So far, there are no specific vaccines or medicines that are effective against COVID-19. Both are under research and development.
Vaccine development is very expensive and time consuming. Only four pharmaceutical makers can withstand that risk: Pfizer, Merck, GlaxoSmithKline and Sanofi. Therefore, government subsidies are also substantial in this area. These include the Biomedical Advanced Research and Development Agency (BARDA) and the Coalition for Epidemic Infectious Diseases Inovation (CEPI).
Company | Country of Citizenship |
---|---|
Roche | Switzerland |
Pfizer | USA |
Novartis | Switzerland |
Merck | USA |
GSK | United Kingdom |
J&J | USA |
Sanofi | France |
AbbVie | USA |
Takeda Pharmaceutical Company | Japan |
Bristol | USA |
Reference: https://answers.ten-navi.com/pharmanews/18365/ Other references: https://www.value.today/world-top-companies/health-care
First, let's download the stock price and make a graph. Get ready first.
Jupyter notebook and pandas-datareader are recommended for downloading data using Python3. For the installation of jupyter notebook, refer to System trade starting with Python3: Installing Jupyter notebook. There are also instructions for installing pandas-datareader here. Also, please refer to I downloaded the stock price from Yahoo Finance US.
%matplotlib inline
import matplotlib.pyplot as plt #Drawing library
import pandas_datareader.data as web #Data download library
import numpy as np
import pandas as pd
import seaborn as sns
Next, download and visualize the TOP10 stock prices.
TOP10=['RHHBY','PFE','NVS','MRK','GSK','JNJ','SNY','ABBV','TAK','BMY']
i=1
for asset in TOP10:
tsd = web.DataReader(asset,"yahoo","1980/1/4").dropna()#jpy
tsd=tsd/tsd.iloc[0]
ts=np.log(tsd.loc[:,'Adj Close'].dropna())
(ts).plot(label=str(asset))
print(asset,adfuller((ts),regression='nc')[1:3],
adfuller((ts),regression='c')[1:3],
adfuller((ts),regression='ct')[1:3],
adfuller((ts),regression='ctt')[1:3])
if i==5:
plt.legend()
plt.show()
i=0
i+=1
The ETF that invests in well-known bio-related stocks in the United States is IBB. Since the profitability of bio stocks became a problem as part of the election campaign by Hillary Clinton in 2015, it has been on a downward trend.
tsd = web.DataReader("IBB","yahoo","2009/1/4").dropna()#jpy
np.log(tsd.loc[:,'Adj Close']).plot()
A well-known healthcare-related ETF in the United States is XLV.
tsd = web.DataReader("xlv","yahoo","2009/1/4").dropna()#jpy
np.log(tsd.loc[:,'Adj Close']).plot()
code | Brand | development of | partner |
---|---|---|---|
AMGN | Amgen Inc. | Antibody treatment, psoriasis treatment | ADPT |
ADPT | Adaptive Biotechnologies Corporation | Antibody treatment | AMGN |
CYDY | CytoDyn Inc. | Therapeutic(leronlimab) | |
GILD | Gilead Sciences, Inc | Therapeutic(remdesivir) | |
MRK | Merck&Co.,Inc | Therapeutic(Ivermectin) | Developed by Satoshi Omura, Special Honorary Professor of Kitasato University |
RHHBY | Roche Holding AG | Therapeutic | Chugai(Under the Roche Group) |
VIR | Vir Biotechnology Inc. | Therapeutic(Monoclonal antibodies) | Wuxi Biologics(china),GSK(Investment),ALNY,BIIB(Vaccine manufacturing) |
ALNY | Alnylam Pharmaceuticals, Inc. | Therapeutic | Vir |
code | Brand | development of | partner |
---|---|---|---|
ALT | Altimmune, Inc. | Protein-based vaccine | |
BNTX | BioNTech SE | mRNA vaccine | PFE, Shanghai Fosun Pharm |
HTBX | Heat Biologics, Inc. | mRNA vaccine | Sanofi |
INO | Inovio Pharmaceuticals, Inc. | DNA vaccine | Bill&Melinda Gates Foundation |
JNJ | Johnson & Johnson | vaccine(Adenovirus) | china |
MRNA | Moderna, Inc. | RNA vaccine | |
NVAX | Novavax, Inc. | Recombinant vaccine | EBS(Vaccine manufacturing) |
AZN | AstnaZeneka | vaccine(Adenovirus) | Oxford University |
TBIO | Translate Bio, Inc. | vaccine | SNY |
code | Brand | development of | partner |
---|---|---|---|
GSK | GlaxoSmithKline plc | Vaccines, remedies | SNY(vaccine),Vir(Therapeutic) |
REGN | Regeneron Pharmaceuticals, Inc. | Vaccines, inhibitors(COV2) | SNY(Therapeutic) |
SNY | Sanofi | vaccine,Therapeutic | GSK(vaccine), TBIO(vaccine)、SNY(Therapeutic) |
:-: | :-: | :-: | :-: |
PFE | Pfizer Inc. | Inhibitor drug | BNTX(vaccine) |
BIIB | Biogen Inc. | ||
EBS | Emergency Bio Solutions | Vaccine manufacturing |
"Basic concept of vaccination" wants to learn the basic knowledge of vaccines This is the most recommended material for people.
Coronavirus vaccines have been developed using a variety of technologies. Most of these vaccines are treated with so-called spike proteins, which help the SARS-CoV-2 coronavirus invade human cells. The immune system can grab spike proteins and make antibodies that stop the virus from entering. Coronavirus vaccines tell people's immune system to make antibodies to the virus without causing disease. Vaccines are composed of whole pathogens or parts of pathogens, and are classified into attenuated vaccines (live vaccines), inactivated vaccines, recombinant subunit vaccines, toxoids, and polysaccharide-protein-binding vaccines.
A vaccine that modifies the entire coronavirus to function the immune response.
Most vaccines used today incorporate inactivated or attenuated viruses that cannot cause the disease. When immune cells recognize them, they make antibodies.
Making these vaccines often means growing the virus. Influenza vaccines are usually raised in chicken eggs, while other vaccines are raised in tanks full of floating cells. These steps can take months to produce a new vaccine.
Example: All conventional vaccines for flu, chickenpox, measles, mumps and rubella fall into this category.
Many of these are inactivated vaccines.
A vaccine that uses a virus to deliver a coronavirus gene to cells.
The virus is very good at invading cells. Since the 1990s, researchers have been researching ways to use these properties to deliver genes to cells and protect people from disease.
A virus called adenovirus, to which the corona spike protein gene has been added, invades cells and unloads the gene. Adenovirus lacks one of its own genes, so it cannot replicate itself and is therefore safe.
Examples: rabies and distemper, H.I.V., Ebola vaccine.
A vaccine that uses a coronavirus protein or protein fragment.
Some vaccines are particles that contain fragments of viral proteins. They are not real viruses, so they do not cause disease, but they can show the immune system what the coronavirus proteins look like.
Example: HPV (human papillomavirus) vaccine (inactivated).
It is a precipitated inactivated vaccine that applies genetic recombination technology. The antigen produced by yeast is adsorbed on an adjuvant (aluminum salt). Coronavirus vaccines by this method contain the entire spike protein or small fragments of the protein.
Example: Shingles and hepatitis B vaccine.
A vaccine that uses part of the genetic code of the coronavirus.
Many experimental coronavirus vaccines do not deliver the entire virus. Instead, they give instructions to build viral proteins. The protein then stimulates the immune system to make antibodies, helping to strengthen other defenses against the coronavirus.
One such genetic technique is known as the DNA vaccine. The designed ring of DNA is delivered to the cell. Cells read viral genes, make copies into molecules called messenger RNA, and use mRNA to assemble viral proteins. The immune system detects proteins and begins defense.
A prototype DNA vaccine based on spike proteins works in monkeys for coronavirus.
Examples: canine melanoma and horse West Nile virus. No DNA vaccine has been approved for use in humans, but researchers are testing to see if it works for diseases such as Zika and the flu.
Some researchers want to skip DNA and instead deliver messenger RNA to cells. The cell reads the mRNA and makes spike proteins that provoke an immune response.
Both RNA and DNA vaccines can be produced faster than traditional methods.
Example: There is no approved RNA vaccine, but clinical trials for MERS and other diseases are underway.
Developer | Method |
---|---|
Applied DNA Sciences/Takis Biotech | DNA/RNA vaccine |
Anges/Osaka University | DNA vaccine |
Innovio | mRNA vaccine |
Imperial College London | DNA/RNA vaccine |
Cure back | DNA/RNA vaccine |
Zydas cast | DNA/RNA vaccine |
Translate Bio | mRNA vaccine |
Biontech | mRNA vaccine |
Moderna | RNA vaccine |
Eye bio | Protein based |
Ultimune | Protein based |
Vaxalt | Protein based |
Vaxil Bio | Protein based |
Expression | Protein based |
Oxford University/Advent | Protein based |
University of Queensland | Protein based |
GlaxoSmithKline | Protein based |
Generax Biotechnology | Protein based |
Nova Bucks | Recombinant protein vaccine |
Baylor College of Medicine/New York Blood Center | Protein based |
Oxford University/AstraZeneca | Viral vector vaccine |
Cansino Biologics | Viral vector vaccine |
Grefex | Viral vector vaccine |
J&J | Viral vector vaccine |
Geobox Lab/Bravovax | Viral vector vaccine |
Tonics | Viral vector vaccine |
Codegenics | Attenuated |
ID Pharma/Fudan University Shanghai Public Health Clinical Center | ? |
source: statista
code | dividend | Investment / assistance | Activity base | Other |
---|---|---|---|---|
ADPT | USA | |||
ALNY | USA | |||
ALT | USA | |||
AMGN | 2.85% | USA | ||
AZN | 2.53% | United Kingdom | ||
BIIB | USA | |||
BNTX | PFE | Germany | ||
CYDY | USA | |||
EBS | USA | |||
GILD | 3.68% | USA | EUA | |
GSK | 4.60% | BARDA | USA | |
HTBX | USA | |||
INO | CEPI,Bill&Melinda Gates Foundation | USA | Clinical trial | |
JNJ | 2.75% | BARDA | USA | Clinical trial, replication virus carrier type |
MRK | 3.19% | USA | ||
MRNA | CEPI,BARDA | USA | Clinical trial | |
NVAX | CEPI,EBS | Australia | ||
PFE | 4.08% | USA | ||
REGN | USA | |||
RHHBY | 2.56% | BARDA | Switzerland | |
SNY | 3.58% | BARDA | France | Clinical trial, anti-thickness auxiliary genetically modified type |
TBIO | USA | |||
VIR | USA | |||
Sinovax | China | |||
CanSino | China | |||
Medicago | (Mitsubishi Tanabe Pharma) |
https://media.rakuten-sec.net/articles/print/26715
CORNA=['GILD','AMGN','BIIB','REGN','ADPT','ALT','BNTX','MRNA','CYDY','GSK','HTBX',
'INO','NVAX','SNY','RHHBY','TBIO','VXRT','ALNY','VIR','JNJ','PFE','AZN','EBS']
Next, let's graph the corona.
i=1
for asset in CORNA:
tsd = web.DataReader(asset,"yahoo","1980/1/4").dropna()#jpy
tsd=tsd/tsd.iloc[0]
ts=np.log(tsd.loc[:,'Adj Close'].dropna())
(ts).plot(label=str(asset))
plt.legend()
print(asset,adfuller((ts),regression='nc')[1:3],
adfuller((ts),regression='c')[1:3],
adfuller((ts),regression='ct')[1:3],
adfuller((ts),regression='ctt')[1:3])
if i==5:
plt.show()
i=0
i+=1
Let's change the period from 2016 onwards.
wiki COVID-19 drug development wiki COVID-19 vaccine wiki Phases of clinical research
"System trade starting with Python 3" "Technical Analysis of Schwagger"Recommended Posts